Excellence is just the beginning.


French German Italian Portuguese Russian

Myelodysplastic Syndromes and Myeloproliferative Neoplasms Services — Clinical Trials

Treatment Study for Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia

Phase II part 2 expansion of oral rigosertib in combination with azacitidine in patients with myelodysplastic syndrome or acute myeloid leukemia.